Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Hay

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 23, 2018
Innate immunity in stem cell-derived hepatocytesLena Fischer, David C Hay, Cliona O'Farrelly
Cellular and Molecular Life Sciences : CMLS|November 29, 2017
Liver cell therapy: is this the end of the beginning?Salamah M Alwahsh, Hassan Rashidi, David C Hay
Toxicology|August 3, 2010
Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screeningSebastian Greenhough, Claire N Medine, David C Hay
Biochemical Society Transactions|July 28, 2010
Role of stem-cell-derived hepatic endoderm in human drug discoveryClaire N Medine, Sebastian Greenhough, David C Hay
Stem Cells (Dayton, Ohio)|March 3, 2004
Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cellsDavid C Hay, Linda Sutherland, John Clark, et al.
Cellular Reprogramming|February 6, 2013
Development of an embryoid body-based screening strategy for assessing the hepatocyte differentiation potential of human embryonic stem cells following single-cell dissociationSebastian Greenhough, Helen Bradburn, John Gardner, et al.
Journal of Visualized Experiments : Jove|May 26, 2020
Introducing Point Mutations into Human Pluripotent Stem Cells using Seamless Genome EditingYu Wang, Andrew J H Smith, David C Hay
Clinical Epigenetics|July 20, 2019
Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenomeMatthew C Sinton, David C Hay, Amanda J Drake
The Journal of Bone and Joint Surgery. American Volume|September 3, 2009
Third-degree heart block associated with bupivacaine infusion following total knee arthroplasty. A case reportDavid C Hay, Robert E Mayle, Stuart B Goodman
Annual Review of Pharmacology and Toxicology|January 9, 2013
Pluripotent stem cell-derived hepatocytes: potential and challenges in pharmacologyDagmara Szkolnicka, Wenli Zhou, Balta Lucendo-Villarin, et al.
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 23, 2018
Innate immunity in stem cell-derived hepatocytesLena Fischer, David C Hay, Cliona O'Farrelly
Cellular and Molecular Life Sciences : CMLS|November 29, 2017
Liver cell therapy: is this the end of the beginning?Salamah M Alwahsh, Hassan Rashidi, David C Hay
Toxicology|August 3, 2010
Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screeningSebastian Greenhough, Claire N Medine, David C Hay
Biochemical Society Transactions|July 28, 2010
Role of stem-cell-derived hepatic endoderm in human drug discoveryClaire N Medine, Sebastian Greenhough, David C Hay
Stem Cells (Dayton, Ohio)|March 3, 2004
Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cellsDavid C Hay, Linda Sutherland, John Clark, et al.
Cellular Reprogramming|February 6, 2013
Development of an embryoid body-based screening strategy for assessing the hepatocyte differentiation potential of human embryonic stem cells following single-cell dissociationSebastian Greenhough, Helen Bradburn, John Gardner, et al.
Journal of Visualized Experiments : Jove|May 26, 2020
Introducing Point Mutations into Human Pluripotent Stem Cells using Seamless Genome EditingYu Wang, Andrew J H Smith, David C Hay
Clinical Epigenetics|July 20, 2019
Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenomeMatthew C Sinton, David C Hay, Amanda J Drake
The Journal of Bone and Joint Surgery. American Volume|September 3, 2009
Third-degree heart block associated with bupivacaine infusion following total knee arthroplasty. A case reportDavid C Hay, Robert E Mayle, Stuart B Goodman
Annual Review of Pharmacology and Toxicology|January 9, 2013
Pluripotent stem cell-derived hepatocytes: potential and challenges in pharmacologyDagmara Szkolnicka, Wenli Zhou, Balta Lucendo-Villarin, et al.
Pageof 13